Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.97 USD | -0.40% | -9.11% | +15.24% |
Financials (USD)
Sales 2024 * | 231M | Sales 2025 * | 233M | Capitalization | 241M |
---|---|---|---|---|---|
Net income 2024 * | 13M | Net income 2025 * | 14M | EV / Sales 2024 * | 1.04 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.03 x |
P/E ratio 2024 * |
19.3
x | P/E ratio 2025 * |
29.5
x | Employees | 185 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.88% |
Latest transcript on Puma Biotechnology, Inc.
1 day | -3.48% | ||
1 week | -9.11% | ||
Current month | -5.85% | ||
1 month | +7.08% | ||
3 months | -2.54% | ||
6 months | +104.51% | ||
Current year | +15.24% |
Managers | Title | Age | Since |
---|---|---|---|
Alan Auerbach
CEO | Chief Executive Officer | 54 | 10-09-14 |
Maximo Nougues
DFI | Director of Finance/CFO | 55 | 18-11-04 |
Alvin Wong
CTO | Chief Tech/Sci/R&D Officer | 71 | 13-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 18-02-22 |
Jay Moyes
BRD | Director/Board Member | 70 | 12-04-26 |
Alan Auerbach
CEO | Chief Executive Officer | 54 | 10-09-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 4.99 | -3.48% | 289 054 |
24-04-17 | 5.17 | +1.37% | 248,185 |
24-04-16 | 5.1 | -4.67% | 285,862 |
24-04-15 | 5.35 | +1.52% | 266,547 |
24-04-12 | 5.27 | -4.01% | 221,709 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.24% | 241M | |
-1.82% | 41.35B | |
+42.21% | 40.38B | |
+2.56% | 39.05B | |
-12.11% | 26.67B | |
+3.09% | 24.07B | |
-24.16% | 18.36B | |
+22.12% | 11.6B | |
-3.74% | 11.68B | |
+7.75% | 11.15B |
- Stock Market
- Equities
- PBYI Stock